Sign in
4/A

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-19-025125

CBO & EVP sold 832 shares at $65.52 ($54,513)

  • CBO & EVP acquired 7,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kassberg Thomas Richard · CBO & EVP

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-01 Grant or award : show line 1 in the form +7,000 90,306 D
2019-03-05 Sale : show line 2 in the form −832 $65.52 $54,513 89,474 D
Open-market sales · 832 sh · avg $65.52 · $54,513

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-01 Grant or award : show line 3 in the form Stock Option (Right to Buy) +21,500 $67.55 2029-03-01 21,500 21,500 D
Loading xslF345X03/doc4a.xml…